S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review - Victor Constantinescu, Rocco Haase, Katja Akgün, Tjalf Ziemssen, 2022
Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis | Neurotherapeutics
Action mechanism of fingolimod and other S1P receptor modulators.... | Download Scientific Diagram
The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators | Neurology
Sphingosine-1-phosphate Receptor Modulators in Multiple Sclerosis | touchNEUROLOGY
Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions - The Lancet
Sphingosine-1-phosphate Receptor Modulators in Multiple Sclerosis | touchNEUROLOGY
Sphingosine-1-Phosphate Modulators for Multiple Sclerosis - Practical Neurology
Summary of S1P receptor modulators currently undergoing or completed in... | Download Table
S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review - Victor Constantinescu, Rocco Haase, Katja Akgün, Tjalf Ziemssen, 2022
Sphingosine 1-phosphate receptor modulators for the treatment of inflammatory bowel disease and other immune-mediated diseases | Medicinal Chemistry Research
Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects | Drugs